![1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug]()
1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer DrugVermathen, Martina; Paul, Lydia E. H.; Diserens, Gaëlle; Vermathen, Peter; Furrer, Julien; Monleon, Daniel · PLOS ONE · 2015